Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y₁₂ Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study

Khan, JN, Greenwood, JP, Nazir, SA et al. (12 more authors) (2016) Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y₁₂ Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study. Journal of the American Heart Association, 5 (6). e003403.

Abstract

Metadata

Authors/Creators:
  • Khan, JN
  • Greenwood, JP
  • Nazir, SA
  • Lai, FY
  • Dalby, M
  • Curzen, N
  • Hetherington, S
  • Kelly, DJ
  • Blackman, D
  • Peebles, C
  • Wong, J
  • Flather, M
  • Swanton, H
  • Gershlick, AH
  • McCann, GP
Copyright, Publisher and Additional Information: © 2016, The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: antiplatelet therapy; cardiovascular magnetic resonance; infarct size; myocardial infarction; primary percutaneous coronary intervention
Dates:
  • Published: 1 June 2016
  • Accepted: 9 April 2016
  • Published (online): 31 May 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 18 Nov 2016 13:37
Last Modified: 05 Oct 2017 16:24
Published Version: https://doi.org/10.1161/JAHA.116.003403
Status: Published
Publisher: Wiley Open Access
Identification Number: https://doi.org/10.1161/JAHA.116.003403

Share / Export

Statistics